Clinical and Diagnostic Laboratory Immunology, July 1998, p. 438-445, Vol. 5, No. 4
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Fels Institute for Cancer Research and Molecular
Biology,1
Departments of Biochemistry
and Neurology,2 and
Department of
Microbiology and Immunology,
Received 13 January 1998/Returned for modification 2 March
1998/Accepted 18 March 1998
We have examined the localization of inducible nitric oxide
synthase (iNOS) and nitrotyrosine (the product of nitration of tyrosine
by peroxynitrite, a highly reactive derivative of nitric oxide [NO])
in demyelinating lesions from (i) two young adult patients with acute
multiple sclerosis (MS), (ii) a child with MS (consistent with diffuse
sclerosis), and (iii) five adult patients with chronic MS. Previous
reports have suggested a possible correlation between iNOS,
peroxynitrite, related nitrogen-derived oxidants, and the demyelinating
processes in MS. We have demonstrated iNOS-immunoreactive cells in both
acute-MS and diffuse-sclerosis-type lesions. In acute-MS lesions, iNOS
was localized in both monocytes/macrophages and reactive astrocytes.
However, foamy (myelin-laden) macrophages and the majority of reactive
astrocytes were iNOS negative. In specimens from the childhood MS
patient, iNOS protein was present only in a subpopulation of reactive
or hypertrophic astrocytes. In contrast, no iNOS staining was detected
in chronic-MS lesions. Immunohistochemical staining of acute-MS lesions
with an antibody to nitrotyrosine revealed codistribution of iNOS- and
nitrotyrosine-positive cells, although nitrotyrosine staining was more
widespread in cells of the monocyte/macrophage lineage. In
diffuse-sclerosis-type lesions, nitrotyrosine staining was present in
hypertrophic astrocytes, whereas it was absent in chronic-MS lesions.
These results suggest that NO and nitrogen-derived oxidants may play a
role in the initiation of demyelination in acute-MS lesions but not in
the later phase of the disease.
*
Corresponding author. Mailing address: Fels Institute
for Cancer Research and Molecular Biology, Temple University School of
Medicine, 3309 North Broad St., Philadelphia, PA 19140. Phone: (215)
707-7657. Fax: (215) 829-1320.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |